While the US FDA looks at paths for providing CBD research and routes to market, Congress may have a further opportunity to encourage legal developments in that direction
Written by CannIntelligence || 18th July 2019 || News analysis | Policy and Politics | Regulation and legislation | US federal regulation | North America United States